Dr. Djaballah has significant industrial experience in preclinical drug discovery, gained over the years in pharmaceutical and biotechnology companies. (sciencemag.org)
After completion of his PhD, he worked in the pharmaceutical industry focusing on preclinical drug discovery for oncology. (actc2018.com)
Carter and his colleagues set up Avalon to aggressively tackle harnessing genomic information to speed up the preclinical drug discovery process. (sciencemag.org)